Showing results (31-40 of 395) with videos related to
Sort By:
Pageof 40
Investigative Ophthalmology & Visual Science|September 28, 2005
Effect of ruboxistaurin on blood-retinal barrier permeability in relation to severity of leakage in diabetic macular edemaCharlotte Strøm, Birgit Sander, Kristian Klemp, et al.Acta Ophthalmologica|January 13, 2010
Delayed response of the retina after hyperbaric oxygen exposurePeter Kristian Kofoed, Pascal W Hasler, Birgit Sander, et al.Frontiers in Neurology|February 21, 2015
Dissociation of Pupillary Post-Illumination Responses from Visual Function in Confirmed OPA1 c.983A > G and c.2708_2711delTTAG Autosomal Dominant Optic AtrophyClaus Nissen, Cecilia Rönnbäck, Birgit Sander, et al.Acta Ophthalmologica|March 9, 2017
Choroideremia: melanopsin-mediated postillumination pupil relaxation is abnormally slowShakoor Ba-Ali, Søren Kirchhoff Christensen, Birgit Sander, et al.Investigative Ophthalmology & Visual Science|January 27, 2005
Retinal artery and vein diameters during pregnancy in diabetic womenMichael Larsen, Lotte Berdiin Colmorn, Marie Bønnelycke, et al.Acta Ophthalmologica|June 16, 2015
Visual outcomes in relation to time to treatment in neovascular age-related macular degenerationAnnette Rasmussen, Sara Brandi, Josefine Fuchs, et al.Acta Ophthalmologica Scandinavica|September 27, 2003
Corneal fluorescence in relation to genetic and environmental factors: a twin studyLine Kessel, Jesper Leth Hougaard, Kirsten Ohm Kyvik, et al.Ugeskrift for Laeger|September 6, 2005
[Treatment of neovascular age-related macular degeneration with intravitreal vascular endothelial growth factor inhibitor--secondary publication]Michael Larsen, Birgit Sander, Jørgen Ebbe Villumsen, et al.Investigative Ophthalmology & Visual Science|June 26, 2003
Evaluation of heredity as a determinant of retinal nerve fiber layer thickness as measured by optical coherence tomographyJesper Leth Hougaard, Line Kessel, Birgit Sander, et al.Acta Ophthalmologica|August 19, 2016
Neovascular age-related macular degeneration treated with ranibizumab or aflibercept in the same large clinical setting: visual outcome and number of injectionsAnnette Rasmussen, Birgit Sander, Michael Larsen, et al.Pageof 40